PMEL and neoplasm: Mice received a sub-cutaneous injection of 105 B16F10 cells in the flank and were treated with anti-PD1 alone, anti-PD1 plus TA99-WT or TA99-Neo2/15, or anti-PD1 in combination with TA99-WT or TA99-Neo2/15 and DLnano-vaccines against Trp2 and Gp100 on D7, 14, 21, 28, 42 and 56 days post tumor inoculation.